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Dendritic cells (DCs) take up soluble- or cell-associated antigens and digest them,  delivering fragments 
to the MHC class I pathway to display antigenic peptides to CD8＋ T cells,  a process known as cross-
presentation.  The pathway requires that,  in order to be degraded by proteosomes,  the extracellular 
antigens must have access to the cytosol across the endosomal membranes.  Although the cross-presen-
tation phenomena was ﬁrst identiﬁed in the 1970s,  the molecular mechanism responsible for the trans-
location is still not fully understood.  In this context,  we have recently found that cytosolic heat shock 
protein (HSP)90 translocates internalized antigen to the cytosol in DCs.  Our results revealed the 
important role that cytosolic HSP90 plays in cross-presentation by pulling out endosomal antigen to the 
cytosol.
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D8＋ and CD4＋ T lymphocytes recognize anti-
genic peptides in the context of MHC class I 
and class II molecules,  respectively.  The peptides 
presented by MHC class I molecules consist of 8-11 
amino acids which are degradation products of endog-
enous cellular proteins by the proteasome.  The pep-
tide-binding groove formed by the α1/α2 domain of 
MHC class I molecules creates a β-sheet ﬂoor sur-
rounded by 2 long α-helices,  yielding pockets to which 
anchor residues bind,  and typically a peptide binds in 
the groove in an extended linear conformation [1].  
Peptides associated with the MHC class II peptide-
binding groove consist of 10-34 amino acids and are 
mostly derived from exogenous proteins internalized 
via phagocytosis/endocytosis.  Thanks to the open ends 
of the peptide-binding groove of MHC class II mole-
cules,  the bound peptides are not limited to a certain 
length.
　 The heat shock proteins (HSPs) are molecular 
chaperones whose expression is elevated by stresses 
such as heat,  in what is called the “heat shock 
response” [2].  HSPs are also referred to as stress 
proteins,  whose expression is increased by conditions 
that cause protein denaturation or unfolding in the 
cells.  Thus,  HSPs are engaged in (i) promoting pro-
tein folding/refolding and preventing aggregation of 
misfolded proteins; (ii) targeting misfolded proteins 
for degradation by the proteasome; and (iii) facilitat-
ing protein transport.  We proposed that the unique 
feature of HSPs― i.e.,  binding to a wide array of 
peptides/proteins―is essential in the traﬃcking and 
degradation of antigens within cells,  and is thus linked 
to antigen processing and presentation.  In this review,  
we provide an overview of the antigen processing 
pathway - endogenous and exogenous antigen process-
ing/presentation pathway,  and consider how HSPs are 
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integrated into the pathway.  Our own recent results 
in this ﬁeld are included in the presentation.
Endogenous Antigen Processing
　 CD8＋ T cells recognize naturally processed pep-
tides presented by MHC class I molecules [3].  
Peptides associated with MHC class I molecules are 
mainly products of cellular proteins degraded by the 
ubiquitin-dependent proteasome system [3].  During de 
novo protein synthesis by the ribosome,  nearly 3ｵ of 
the proteins undergo misfolding,  which occurs mainly 
due to mutational changes in the encoding gene,  tran-
scriptional and translational mistakes,  and unsuccess-
ful protein folding.  These misfolded proteins are 
called defective ribosomal products (DRiPs) and are 
implicated as the main source of antigen peptides 
presented by MHC class I molecules [4] (Fig.  1).
　 DRiPs are prone to aggregation,  there becoming 
good targets of the molecular chaperones HSP70/
HSP40 and HSP90.  These molecular chaperones hold 
DRiPs while recruiting the E3 ubiquitin ligase,  
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Fig. 1　 Nearly 3% of newly synthesized proteins (either self or foreign antigens) on the ribosome undergo misfolded status,  and are 
called DRiPs.  The aggregation-prone DRiPs are dangerous because the aggregates eventually cause cell death.  To prevent this unfortu-
nate scenario,  Hsp70/Hsp40 and Hsp90 sense and hold DRiPs,  while simultaneously recruiting E3-ubiquitin ligases such as CHIP to 
polyubiquitinate for their degradation by the 26S proteasome.  Just a few percentage points of the total amount of the produced peptides 
will enter the ER to associate with the newly synthesized MHC class I heavy chain-β2m complex.  In the case of DRiPs,  it appears that 
these wasted proteins are not truly wasted,  because they are the main source of peptides presented by MHC class I molecules to CD8＋ T 
cells.  Thus,  imperfect ribosomal function makes perfect sense in terms of immune surveillance.
CHIP (carboxyl terminus of HSC70 interacting pro-
tein),  to polyubiquitinate,  which eventually causes 
degradation of DRiPs by the proteasome [5] (Fig.  1).  
This idea has not been formally demonstrated.  
Importantly,  MHC class I expression is not downreg-
ulated in CHIP-deﬁcient cells,  indicating that addi-
tional unknown E3 ubiquitin ligase(s) are involved 
redundantly in the degradation of DRiPs.  A novel E3 
ligase should be identiﬁed so that its involvement in the 
MHC class I antigen processing pathway would be 
fully understood.
　 The peptides generated by the proteasome in the 
cytosol are ferried through transporter associated 
with antigen processing (TAP) molecules into the 
endoplasmic reticulum (ER),  where they associate 
with the MHC class I-β2m complex to form stable tri-
molecular complexes [1].  These peptides are dis-
played on the cell surface in the context of MHC class 
I molecules to activate CD8＋ T cells.
Exogenous Antigen Processing
　 Phagocytes such as dendritic cells (DCs) and mac-
rophages take up extracellular antigens in the endo-
some and/or phagosome and digest them with lyso-
somal enzymes.  Hence,  the proteolytic fragments 
(peptides) are loaded onto MHC class II molecules that 
have been sorted with the guidance of invariant chain 
(Ii) from the ER,  and MHC class II-peptide complexes 
are moved up on the cell surface to display those 
peptides to CD4＋ T cells [6],  thereby stimulating B 
cell-mediated humoral immunity.  Thus,  internalized 
antigens undergo proteolysis in the endosome/lyso-
zome and the resulting peptides are presented to CD4＋ 
T cells.  Should this be the only pathway for presenta-
tion of exogenous antigen by antigen presenting cells 
(APCs),  CD8＋ T cells speciﬁc to viral or tumor 
antigens would never be activated.  To overcome this 
problem,  DCs have the unique ability to forward even 
extracellular antigens from the endosome to the cyto-
sol,  where they are further forwarded to the protea-
some.  The exceptionally specialized machinery seems 
to be utilized to secure the priming of CD8＋ T cells 
after internalization of exogenous antigens [7],  as 
described below.
Cross-presentation Is Essential for Activation 
of CD8＋ T Cells by Exogenous Antigens
　DCs are the most powerful APCs,  able to prime 
naïve T cells to give rise to protective immunity of 
cytotoxic T cells (CD8＋ T cells) against cancers and 
infectious agents [7].  During viral infection or malig-
nant transformation,  any intracellular antigenic altera-
tions in non-APCs must be presented to CD8＋ T cells,  
which is essential in ﬁghting virus-infected cells and 
cancer cells [8].  However,  cancer cells cannot act by 
themselves as professional APCs to prime T cells,  
although they express tumor antigens on the cell sur-
face.  In addition,  DCs do not become infected by 
certain viruses,  and thus cannot present such viral 
antigens directly to CD8＋ T cells.  Therefore,  DCs 
must internalize those neighboring tumor or infected 
cells,  digesting them,  and then present antigen pep-
tides to CD8＋ T cells in the context of MHC class I 
molecules.  This pathway is called cross-presentation 
[9],  and is believed to be speciﬁc to DCs,  not other 
types of APCs such as macrophages or B cells.  In 
DCs,  signiﬁcant proportions of exogenous antigens 
within the endosome are translocated to the cytosol 
[10],  and degraded by the 26S proteasome to render 
the peptides presentable by MHC class I molecules.  
The produced peptides enter the ER through TAP 
molecules to associate with MHC class I molecules,  
and move up on the cell surface to activate CD8＋ T 
cells.
Mechanism of Antigen Translocation from the 
Endosome to the Cytosol
　 In cross-presentation,  the pathway through which 
exogenous antigens can access MHC class I molecules 
is not fully understood.  The delivery of exogenous 
proteins within the endosome to the cytosol might 
require the same protein complex machinery that is 
responsible for the dislocation of misfolded proteins in 
the ER.  ER-misfolded proteins dislocated to the 
cytosol are polyubiquitinylated for degradation by the 
26S proteasome,  a process known as the ER-associated 
degradation (ERAD) pathway [11,  12].  A mechanis-
tic explanation of the cross-presentation can be found 
in the indirect observation that the ER membranes 
may fuse with the nascent phagosome,  referred to as 
the ER-phagosome fusion [13].  ER-phagosome fusion 
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allows internalized exogenous antigens to dislocate to 
the cytosol,  followed by degradation by the protea-
some,  resulting in the production of antigen peptides 
presentable by MHC class I molecules [14,  15].  If 
this is true,  the pore structure for translocation of the 
antigen to the cytosol is the Sec61 complex,  which is 
utilized for dislocation of ER-misfolded proteins to the 
cytosol by the ERAD pathway.  Pseudomonas aeruginosa 
Exotoxin A,  an inhibitor for retro-translocation of 
ER-misfolded proteins,  substantially blocked cross-
presentation [10].  However,  there is still contro-
versy as to whether the Sec61 is required for cross-
presentation,  because the toxin has been reported to 
bind AAA ATPase cdc48 (in yeast)/p97 (in mammals) 
but not the Sec61 complex [10].
　 Exogenous proteins in the endosome must be rela-
tively unfolded before being translocated to the cyto-
sol,  since the size of the membrane pore is not large 
enough for escape in keeping its native form [16,  17].  
Such unfolded proteins are reminiscent of the DRiPs.  
If the unfolded antigen is similar to DRiPs,  it must 
ﬁrst be recognized by HSPs,  both in the endosome 
and cytosol,  for its smooth translocation and then re-
folded or degraded by the proteasome.  In this context,  
HSPs might play critical roles that will be discussed 
in the next section.  
Indispensable Role of HSP90 in Antigen Cross-
presentation
　 In considering how HSPs are involved in cross-
presentation (in terms of translocation of endosomal 
antigens to the cytosol),  there might be 2 distinct 
mechanisms.  First,  HSPs direct CHIP-mediated 
polyubiquitinylation of retro-translocated unfolded 
proteins for proteasomal degradation.  Second,  HSPs 
direct retro-translocation of proteins from the endo-
some to cytosol,  a mechanism that is supported by 
evidence that Grp78 and cytosolic HSP70/HSP90 
drive polypeptide into the ER and the mitochondria,  
respectively.  Our recent observations clearly indicate 
that HSPs play a pivotal role in antigen traﬃcking,  
which links to antigen cross-presentation.
　 We recently found that molecular chaperones such 
as HSP90 play important roles in this antigen cross-
presentation [18,  19].  The main results we obtained 
are as follows.
　 1. We generated HSP90α-deﬁcient mice by the 
homologous recombination method.  Cross-presentation 
was signiﬁcantly downregulated in bone-marrow-
derived dendritic cells (BMDC) of HSP90α-deﬁcient 
mice,  although endogenous antigen processing/pre-
sentation was only marginally aﬀected.  Also,  cross-
priming of HSP90α-deﬁcient mice after immunization 
with cell-associated antigen was downregulated.  We 
originally expected that HSP90α deﬁciency would be 
embryonic lethal,  since HSP90α is highly expressed 
in mouse ES cells,  which suggests it would play an 
essential role in fetal development.  Surprisingly,  
however,  we found that the mice survived and grew 
normally although male mice had azospermia in the 
testis.  The HSP90α-deﬁcient mice allowed us to 
analyze the role of HSP90α in the translocation of 
extracellular antigen into the cytosol.
　 2. Image stream analysis suggested that internal-
ized extracellular antigen was translocated to the 
cytosol in an HSP90-dependent manner.
　 3. Chemical inhibitors of HSP90 blocked the 
association of extracellular antigen with cytosolic 
HSP90 and translocation of antigen into the cytosol,  
and thereby blocked cross-presentation.
　 4. An antigen translocation assay with puriﬁed 
endosomes containing extracellular antigen revealed 
that HSP90 is suﬃcient to pull antigen out of the 
endosome and into the cytosol.
　 5. As previously demonstrated,  in vivo administra-
tion of cytochrome c induces apoptosis of CD8＋ DCs,  
because this DC subset is mainly involved in antigen 
cross-presentation.  Extracellular cytochrome c is 
internalized and translocated from endosome to cyto-
sol,  resulting in induction of apoptosis.  Importantly,  
the reduction of CD8＋ DC numbers is eliminated in 
HSP90α-deﬁcient mice,  indicating that the transloca-
tion of cytochrome c into the cytosol is impaired in 
these mice.
　 A schematic incorporating our ﬁndings in a possible 
mechanism of the cross-presentation of extracellular 
antigen is depicted in Fig.  2.
Concluding Remarks
　 For cross-presentation,  extracellular antigen uptake 
into endosomes is followed by translocation of the 
internalized antigen from endosomes to the cytosol for 
proteasomal degradation.  A major unresolved issue,  
which has been a mystery since the discovery of the 
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cross-presentation phenomena in the 1970s,  is how the 
antigen within endosome/phagosomes can be trans-
ferred across the membranes of these organelles for 
proteolysis in the cytosol.  We believe that our ﬁnd-
ings,  at least in part,  have resolved the decades old 
issue.
　 Finally,  growth factors such as ﬁbroblast growth 
factor (FGF)-1/2 [20] and certain toxins like diph-
theria toxin appear to utilize HSP90 for their trans-
location into the cytosol in non-antigen-presenting 
cells [21,  22].  In light of these evidences,  the 
HSP90-mediated antigen translocation system might 
have developed as a common mechanism in a variety of 
cells,  causing physiological outcomes such as tran-
scriptional activation [20],  intoxication [21,  22],  
and cross-presentation [18,  19].
References
 1. Cresswell P,  Ackerman LA,  Giodini A,  Peaper DR and Wearsch 
PA: Mechanisms of MHC class I-restricted antigen processing and 
cross-presentation.  Immunol Rev (2005) 207: 145-157.
 2. Lindquist S: The heat-shock response.  Annu Rev Biochem (1986) 
55: 1151-1191.
 3. Rock KL and Goldberg AL: Degradation of cell proteins and the 
generation of MHC class I-presented peptides.  Annu Rev Immunol 
(1999) 17: 739-779.
 4. Schubert U,  Anton LC,  Gibbs J,  Norbury CC,  Yewdell JW and 






MHC class I MHC class I












Fig. 2　 Models for cross-presentation of extracellular antigen by DCs after its translocation into the cytosol by HSP90.  DCs uptake 
extracellular antigen through the endosome/phagosome pathway.  Cytosolic HSP90 binds to the relatively unfolded antigen as it emerges 
across the endosomal membranes through a putative translocon (Sec61 complex ?) and promotes its translocation into the cytosol.  Once 
the extracellular antigen appears in the cytosol it can be processed by the conventional MHC I pathway: degraded by the proteasome into 
short peptides that are loaded onto MHC I molecules in the ER.  CD8＋ T cells then recognize the MHC class I-epitope complex on the cell 
surface.  In model 2,  the proteasome is attached on the cytosolic face of the ER-phagosome and immediately degrades the translocated 
antigen into short peptides.  The peptides then re-enters into the ER-phagosome from which they are translocated.
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